Sabina Glozman

This inventor holds 8 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: Vecta, Ltd., Targia Pharmaceuticals, Avita Iinternational Ltd.. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabina Glozman. Retrieved from https://idiyas.com/inventor/sabina-glozman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 10)

% Patents Active = 12.5

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 46(Granted Patents)

Location History:

Rehovot, IL (2007 - 2016)
Naharya, IL (2014 - 2017)

Company Filing History:

Targia Pharmaceuticals

patents

1 out of 1

Avita Iinternational Ltd.

where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9790468 - Multifunctional immature dental pulp stem cells and therapeutic applications (2017-10-17),

2. 9579299 - CNS pharmaceutical compositions and methods of use (2017-02-28),

3. 9370481 - Compositions and methods for inhibiting gastric acid secretion (2016-06-21),

4. 9278080 - Compositions and methods for inhibiting gastric acid secretion (2016-03-08),

5. 8729070 - CNS pharmaceutical compositions and methods of use (2014-05-20),

6. 7981908 - Compositions and methods for inhibiting gastric acid secretion (2011-07-19),

7. 7803817 - Composition and methods for inhibiting gastric acid secretion (2010-09-28),

8. 7271146 - [object Object] (2007-09-18),

Title: The Innovative Mind of Sabina Glozman

Introduction

Sabina Glozman, an accomplished inventor based in Naharya, IL, has made significant contributions to the field of biomedical innovations. With a portfolio of eight patents, her work focuses on therapeutic applications that hold promise for enhancing medical treatments and addressing various health challenges.

Latest Patents

Among her latest innovations, Glozman has developed multifunctional immature dental pulp stem cells (IDPSCs) and their applications in mitigating degenerative diseases. This invention presents IDPSCs along with multi-lineage compositions aimed at reducing the risks associated with degenerative conditions, in addition to offering medicinal and aesthetic benefits. Furthermore, she has created CNS pharmaceutical compositions designed to minimize side effects associated with CNS active agents, incorporating vagal neuromodulators to enhance therapeutic efficacy while reducing somnolence.

Career Highlights

Sabina Glozman has demonstrated her expertise and dedication through her work with leading companies in the pharmaceutical sector, including Vecta Ltd. and Targia Pharmaceuticals. Her innovative approaches and research-driven mindset have positioned her as a thought leader within her field.

Collaborations

Throughout her career, Glozman has collaborated with talented colleagues, such as Aleksey Kostadinov and Ayelet David. These partnerships have facilitated knowledge exchange and the evolution of her groundbreaking inventions, contributing to advancements in medical technology.

Conclusion

Sabina Glozman's portfolio of patents showcases her commitment to innovation in the biomedical field. Her latest developments, especially in the realms of dental pulp stem cells and CNS pharmaceutical compositions, reflect her ability to address pressing health issues while paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.